EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Dual antiplatelet pre-treatment with aspirin and ticagrelor in ACS patients undergoing unplanned aortocoronary bypass surgery

Christian Salbach, Mustafa Yildirim, Rebecca Gulba, Barbara Ruth Milles, Moritz Biener, Matthias Mueller-Hennessen, Hauke Hund, Norbert Frey, Evangelos Giannitsis

Clinical Research in Cardiology · 2025

DOI: 10.1007/s00392-025-02629-0 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Clinical Research in Cardiology, 2025. Verfasst von Christian Salbach und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine III, Cardiology, University Hospital of Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany. Hauptthemen laut MEDLINE: Ticagrelor, Coronary Artery Bypass, Aspirin, Acute Coronary Syndrome. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsklinikum Heidelberg.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Major bleedings following coronary artery bypass grafting (CABG) have significant implications on outcomes in acute coronary syndrome (ACS) patients. Owing fears of fatal bleedings in case of urgent CABG, current guidelines recommend a cessation of P2Y 12 receptor antagonists (P2Y 12 -RA) before cardiac surgery and opt against routine pre-treatment with a P2Y 12 -RA before coronary angiography (CA). However, sparse information exists outside randomized trials on the frequency of urgent CABG and the consequences of inappropriately long cessation of P2Y 12 -RA treatment in patients presenting with ACS.

Methods

In this observational single-center study, ACS patients presenting to an emergency department requiring a CABG were recruited consecutively during a 2-year enrolment period. Baseline characteristics, CABG-related bleedings and all-cause mortality were collected from electronical medical records and related to the timing of CABG and P2Y 12 -RA cessation.

Results

A total of 1,502 ACS patients were included, herein 102 (6.8%) underwent urgent CABG. The majority (76.5%) received a routine P2Y 12 -RA pre-treatment predominantly ticagrelor in addition to low-dose aspirin before CA. 31 (30.4%) developed a CABG-related bleeding event. Bleeding probability was highest (HR: 4.77, 95%CI 2.20–10.37, p = 0.0001) when CABG was performed within 24 h after administration of dual anti-platelet therapy (DAPT). Despite high utilization rates of DAPT pre-treatment and high prevalence of CABG-related major bleedings, no fatal bleedings occurred.

Conclusions

Need of urgent CABG in ACS is infrequent and does not result in an excess of mortality. However, cessation of ticagrelor for at least 48 h before CABG is recommended to minimize rates of CABG-related bleedings. Graphical Abstract

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TicagrelorCoronary Artery BypassAspirinAcute Coronary SyndromePlatelet Aggregation InhibitorsDual Anti-Platelet TherapyPostoperative HemorrhageHumansMaleFemaleAgedMiddle AgedPurinergic P2Y Receptor AntagonistsCoronary AngiographyTreatment Outcome

Stichwörter der Autor:innen

Acute coronary syndromeCoronary artery bypass graftingDual antiplatelet therapyReal-world evidence

Substanzen

TicagrelorAspirinPlatelet Aggregation InhibitorsPurinergic P2Y Receptor Antagonists

Autor:innen und Institutionen

  • Department of Internal Medicine III, Cardiology, University Hospital of Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.
  • Department of Internal Medicine III, Cardiology, University Hospital of Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany. evangelos.giannitsis@med.uni-heidelberg.de.

Förderung

  • Universitätsklinikum Heidelberg

Zitieren

APA

Salbach, C., Yildirim, M., Gulba, R., Milles, B. R., Biener, M., Mueller-Hennessen, M., Hund, H., Frey, N., & Giannitsis, E. (2025). Dual antiplatelet pre-treatment with aspirin and ticagrelor in ACS patients undergoing unplanned aortocoronary bypass surgery. Clinical Research in Cardiology. https://doi.org/10.1007/s00392-025-02629-0

Vancouver

Salbach C, Yildirim M, Gulba R, Milles BR, Biener M, Mueller-Hennessen M, et al. Dual antiplatelet pre-treatment with aspirin and ticagrelor in ACS patients undergoing unplanned aortocoronary bypass surgery. Clinical Research in Cardiology. 2025. doi:10.1007/s00392-025-02629-0

BibTeX
@article{Salbach2025,
  author = {Salbach, Christian and Yildirim, Mustafa and Gulba, Rebecca and Milles, Barbara Ruth and Biener, Moritz and Mueller-Hennessen, Matthias and Hund, Hauke and Frey, Norbert and Giannitsis, Evangelos},
  title = {Dual antiplatelet pre-treatment with aspirin and ticagrelor in ACS patients undergoing unplanned aortocoronary bypass surgery},
  journal = {Clinical Research in Cardiology},
  year = {2025},
  doi = {10.1007/s00392-025-02629-0}
}
Kostenlos starten →